APA (7th ed.) Citation

DR, B., LB, P., J, D., DA, F., & BA, H. (2024). Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial. Journal of substance use and addiction treatment, 164, 209438. https://doi.org/10.1016/j.josat.2024.209438

Chicago Style (17th ed.) Citation

DR, Balter, Puglisi LB, Dziura J, Fiellin DA, and Howell BA. "Buprenorphine-naloxone Vs. Extended-release Naltrexone for Opioid Use Disorder in Individuals with and Without Criminal Legal Involvement: A Secondary Analysis of the X:BOT Randomized Controlled Trial." Journal of Substance Use and Addiction Treatment 164 (2024): 209438. https://doi.org/10.1016/j.josat.2024.209438.

MLA (9th ed.) Citation

DR, Balter, et al. "Buprenorphine-naloxone Vs. Extended-release Naltrexone for Opioid Use Disorder in Individuals with and Without Criminal Legal Involvement: A Secondary Analysis of the X:BOT Randomized Controlled Trial." Journal of Substance Use and Addiction Treatment, vol. 164, 2024, p. 209438, https://doi.org/10.1016/j.josat.2024.209438.